Skip to main content

View Resource

Published

Risk of dengue following prior SARS-CoV-2 infection: a population-based cohort study.
Wee LE. The Lancet Regional Health – Western Pacific 2025;:https://doi.org/10.1016/j.lanwpc.2025.101727.
[Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly Omicron). While not irrefutable proof for possible antibody-dependent enhancement of DENV3-infection post-Omicron COVID-19, given modest effect sizes, future studies can shed more light on potential interactions. Public health strategies (e.g., vaccination) remain important in tropical/subtropical regions where COVID-19/DENV are now endemic.]
Freely available online
Age Groups
Adults
Conditions and Lifestyle Factors
Coronavirus Infections
Dengue
Settings
Population Health
Staff Groups
Immunisation
Public Health Doctor
Public Health Specialist